Awiqli (insulin icodec)

pCPA File Number: 22715

Negotiation Status:

Under consideration for negotiation

Indication(s):

Diabetes Mellitus, Type 2

Sponsor/Manufacturer:

Novo Nordisk Canada Inc.

CDA-AMC Project Number:

SR0790-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable